This study investigated the effects of Ostokin Plus (liquid form) on bone healing during rapid maxillary expansion (RME) in a controlled setting involving male rats.

 

The research demonstrated that Ostokin Plus (liquid form) significantly enhanced new bone formation in the midpalatal suture, with experimental groups showing up to 53.40% new bone formation compared to 42.68% in the control group.

 

This finding is particularly noteworthy as it indicates that Ostokin Plus (liquid form) can effectively promote bone regeneration during orthodontic procedures, an area where maintaining bone integrity is crucial.

 

The primary outcome measured was the extent of new bone formation, assessed through histological analysis after a 15-day consolidation period. Unlike other treatments that may only slow down bone loss, Ostokin Plus (liquid form) showed a clear improvement in bone healing, suggesting its potential as a valuable aid in orthodontic applications.

 

This study highlights the significant benefits of Ostokin Plus (liquid form) in enhancing bone regeneration, paving the way for further research into its effects on human bone health.